Literature DB >> 11327320

The NADPH oxidase of endothelial cells.

B M Babior1.   

Abstract

The best known NADPH oxidase is that of phagocytes-neutrophils and monocytes. In these cells, the enzyme manufactures large quantities of O2- and other reactive oxidants that are used for the purpose of killing invading microorganisms. Recent studies, however, have suggested that a number of other tissues contain NADPH oxidases. In contrast to the very vigorous production of oxidants by phagocytes, rates of oxidant production by these other cell types are quite low. Oxidant production by these cells is generally thought to serve a signaling function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11327320     DOI: 10.1080/713803730

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  50 in total

Review 1.  Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein.

Authors:  Lawrence J Marnett; James N Riggins; James D West
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 3.  Lung ischemia: a model for endothelial mechanotransduction.

Authors:  Shampa Chatterjee; Kenneth E Chapman; Aron B Fisher
Journal:  Cell Biochem Biophys       Date:  2008-11-04       Impact factor: 2.194

4.  Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.

Authors:  Elizabeth D Hood; Colin F Greineder; Chandra Dodia; Jingyan Han; Clementina Mesaros; Vladimir V Shuvaev; Ian A Blair; Aron B Fisher; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2012-09-06       Impact factor: 9.776

5.  Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells.

Authors:  Meng Xiang; Xiaolian Shi; Yuehua Li; Jia Xu; Lianhua Yin; Guozhi Xiao; Melanie J Scott; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

Review 6.  Redox signaling.

Authors:  Henry Jay Forman; Martine Torres; Jon Fukuto
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling.

Authors:  Sho-ichi Yamagishi; Riichiro Abe; Yosuke Inagaki; Kazuo Nakamura; Hiroshi Sugawara; Daisuke Inokuma; Hideki Nakamura; Tadamichi Shimizu; Masayoshi Takeuchi; Akihiko Yoshimura; Richard Bucala; Hiroshi Shimizu; Tsutomu Imaizumi
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice.

Authors:  Qiuhong Li; Astra Dinculescu; Zhiying Shan; Rehae Miller; Jijing Pang; Alfred S Lewin; Mohan K Raizada; William W Hauswirth
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

Review 9.  Cyclic stretch, reactive oxygen species, and vascular remodeling.

Authors:  Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 10.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.

Authors:  Randall S Frey; Masuko Ushio-Fukai; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.